(Q35185772)

7 August 2017

1 reference

title

Erlotinib: a new therapeutic approach for non-small cell lung cancer (English)

1 reference

7 August 2017

1 reference

Philip Bonomi

1

1 reference

PubMed ID

12882624

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Investigational Drugs

7 August 2017

1 reference

7 August 2017

12

1 reference

7 August 2017

8

1 reference

7 August 2017

1395-1401

1 reference

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

7 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Why the epidermal growth factor receptor? The rationale for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Epidermal growth factor receptor dependence in human tumors: more than just expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

ErbB-targeted therapeutic approaches in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.8.1395

10.1517/13543784.12.8.1395

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12882624